Compound research
NAD+ Research Compound: Product Identity, COAs, and Lot Records

NAD+ is a non-peptide research compound. It belongs in its own documentation path rather than being treated as interchangeable with peptide products elsewhere in a research catalogue. The product name, labeled strength, and identified lot or sample determine what record can be connected to the material under review.
Start with the individual NAD+ listing. Confirm the labeled quantity, product format, current stock status, and available documentation. Each strength is a separate product record, so a result from one strength should not automatically be applied to another.
Read the stated method with the reported result. Identity, relative purity, measured content, and endotoxin status are separate analytical questions. The relevant evidence is the method and result stated for the named sample, not a generalized statement about NAD+ as a compound category.
A product-specific NAD+ COA should identify the material, its lot or sample identifier, issuing laboratory, analysis date, method, and reported result. The lot or sample field limits the evidence to a particular material and stops a generic certificate from being mistaken for a current batch record.
The appropriate verification path is simple: exact product listing, labeled strength, lot or sample identifier, original report, then stated methods and results. Where an exact report is unavailable, the listing should make that documentation status clear instead of substituting a nearby but unmatched certificate.
EVLV supplies NAD+ strictly for lawful laboratory and analytical research. This guide covers product identity and documentation review only. It does not provide medical, veterinary, dosing, administration, or outcome guidance.


